– the leading provider of online annual reports to individual and institutional investors.

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. Its lead product includes Fanapt for the acute treatment of schizophrenia in adults.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports